著者
Tatsuro Aikawa Tetsuro Miyazaki Kazunori Shimada Yurina Sugita Megumi Shimizu Shohei Ouchi Tomoyasu Kadoguchi Yasutaka Yokoyama Tomoyuki Shiozawa Masaru Hiki Shuhei Takahashi Hamad Al Shahi Shizuyuki Dohi Atsushi Amano Hiroyuki Daida
出版者
一般社団法人 日本動脈硬化学会
雑誌
Journal of Atherosclerosis and Thrombosis (ISSN:13403478)
巻号頁・発行日
pp.38315, (Released:2017-03-22)
参考文献数
31
被引用文献数
17

Aim: Omega-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been reported to reduce the risk of cardiovascular disease. However, whether omega-3 PUFAs are involved in the pathogenesis of abdominal aortic aneurysms (AAA) remains unclear.Methods: We analyzed 67 consecutive patients admitted for the elective surgical repair of AAA. We investigated the association of serum EPA and DHA levels as well as the EPA/AA ratio with the size of AAA assessed using three-dimensional reconstructed computed tomography images.Results: Mean patient age was 70±9 years and 60 patients were male. Serum EPA and DHA levels were 75.2±35.7 μg/mL and 146.1±48.5 μg/mL, respectively. EPA/AA ratio was 0.44±0.22, which was lower than those in healthy Japanese subject and equivalent to those in Japanese patients with coronary artery disease as previously reported. Mean of the maximum AAA diameter was 56.4±8.9 mm, and serum EPA levels and EPA/AA ratio negatively correlated with it (r=−0.32 and r=−0.32, respectively). Multiple liner regression analysis showed that EPA levels were significant independent factor contributing to the maximum AAA diameter. Furthermore, low serum EPA levels and low EPA/AA ratio were significantly associated with the growth rate of AAA diameter (r=−0.43 and r=−0.33, respectively).Conclusion: EPA levels in patients with AAA were relatively low. Low serum EPA levels and EPA/AA ratio were associated with the size and growth rate of AAA.
著者
高橋 修平 亀田 貴雄 本山 秀明 Shuhei Takahashi Takao Kameda Hideaki Motoyama
雑誌
南極資料 = Antarctic Record (ISSN:00857289)
巻号頁・発行日
vol.52, no.特集号, pp.117-150, 2008-06-30

本報告は,1991年から2007年(第32次南極地域観測隊から第48次隊)に東南極氷床の内陸域に位置するドームふじ基地を中心として実施された「ドームふじ観測計画」で得られた雪氷・気象観測の主要な成果を取りまとめたものである.現地での雪氷・気象観測は,「基本観測」及び「研究観測」として実施された.前者は,ドームふじ観測計画として立案したものであり,後者は南極地域観測隊に参加した研究者が立案したものである.2001年から2007年(第42次隊から第48次隊)まで実施された第二期ドームふじ観測計画期間での基本観測については,観測方法及び現地での観測実施状況を詳しく述べた.なお,ドームふじ観測計画により得られた雪氷・気象観測結果を報告する論文・報告は現在までに157編,学会等での口頭・ポスター発表は243件であった.
著者
Masaru Hiki Tetsuro Miyazaki Kazunori Shimada Yurina Sugita Megumi Shimizu Tatsuro Aikawa Shohei Ouchi Tomoyuki Shiozawa Kiyoshi Takasu Shuhei Takahashi Atsutoshi Takagi Katsumi Miyauchi Hiroyuki Daida
出版者
一般社団法人 日本動脈硬化学会
雑誌
Journal of Atherosclerosis and Thrombosis (ISSN:13403478)
巻号頁・発行日
pp.37424, (Released:2017-03-24)
参考文献数
27
被引用文献数
9

Aim: Polyunsaturated fatty acids (PUFAs) take part in various biological events linked to the pathogenesis of venous thromboembolism (VTE), including inflammation, endothelial dysfunction, and hypercoagulability. Several studies have demonstrated the association between PUFAs and the occurrence of VTE. However, the role of PUFAs in the pathogenesis of VTE remains unclear.Methods: We enrolled 45 patients with acute VTE and 37 age-, gender-, and body mass index-matched healthy volunteers to examine their PUFA levels. Serum omega 3 (eicosapentaenoic acid: EPA and docosahexaenoic acid: DHA) and omega 6 (dihomogammalinolenic acid: DGLA and arachidonic acid: AA) fatty acids levels were measured within 24 h of admission.Results: Patients with VTE showed significantly higher AA and lower EPA levels, and lower EPA/AA ratios than the controls. Multivariate analysis revealed that AA was an independent marker for VTE. In addition, we divided the patients based on their median age (58 years old). The younger patients with VTE showed significantly lower EPA/AA levels than their age-matched controls, whereas older patients with VTE showed a significantly higher AA/DGLA levels than the older controls.Conclusions: High serum AA levels and low EPA levels are associated with the development of acute VTE, suggesting that the imbalance of PUFAs may be a potential therapeutic target for preventing acute VTE.